CLINICAL_TRIALS
trial_result
· 2022-08-11
Clinical Trial Update: Study Combining Bortezomib With High Dose Melphalan to Treat Multiple Myeloma [Phase 1, Phase 2]
Summary
A Phase 1/2 trial evaluating the combination of bortezomib with high-dose melphalan in multiple myeloma has completed enrollment and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hackensack Meridian Health | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-08-11